Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 11, 1998, Pages 2877-2882

  Blagburn, Byron L ^a   Drain, Kathryn L ^a   Land, Tracey M ^a   Kinard, Rachel G ^a   Moore, P Hutton ^a   Lindsay, David S ^a   Patrick, Donald A ^b   Boykin, David W ^c   Tidwell, Richard R ^b  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,7 DIAMIDINOCARBAZOLE DIHYDROCHLORIDE; CARBAZOLE DERIVATIVE; NITAZOXANIDE; PAROMOMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; ARTICLE; AUTOPSY; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; EXPERIMENTAL INFECTION; MOUSE; NEWBORN; NONHUMAN; OOCYST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031784981     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.11.2877     Document Type: Article

References (26)

1. Bell, C., C. Dykstra, N. Naiman, M. Cory, T. Fairley, and R. Tidwell. 1993. Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition. Antimicrob. Agents Chemother. 37:2668-2673.
2. Blagburn, B., C. Sundermann, D. Lindsay, J. Hall, and R. Tidwell. 1991. Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR swiss mice by polyether ionophores and aromatic amidines. Antimicrob. Agents Chemother. 35:1520-1523.
3. Blagburn, B., and R. Soave. 1997. Prophylaxis and chemotherapy, p. 111-128. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Boca Raton, Fla.
4. Blagburn, B., T. Land, K. Drain, P. Moore, D. Lindsay, D. Boykin, and R. Tidwell. Dicationic furans inhibit development of Cryptosporidium parvum in Hsd/ICR suckling Swiss mice. J. Parasitol., in press.
5. Boykin, D., A. Kumar, J. Spychala, M. Zhou, R. Lombardy, W. Wilson, C. Dykstra, S. Jones, J. Hall, R. Tidwell, C. Laughton, and C. Neidle. 1995. Dicationic diarylfurans as anti-Pneumocystis carinii agents. J. Med. Chem. 38:912-916.
6. Casemore, D., S. Wright, and R. Coop. 1997. Cryptosporidiosis - human and animal epidemiology, p. 65-92. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Boca Raton, Fl, p. 65-92.
7. Donkor, I., R. Tidwell, and S. Jones.. 1994. Pentamidine congeners. 2. Aromatic diamidines and diimidazolines as potential anti-Pneumocystis carinii agents. J. Med. Chem. 37:4554-4557.
8. Doumbo, O., J. Rossignol, E. Pichard, H. Traore, T. Dembele, M. Diakite, F. Traore, and D. Diallo. 1997. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am. J. Trop. Med. Hyg. 56:637-639.
9. Dubovi, E., J. Geratz, and R. Tidwell. 1981. Inhibition of respiratory syncytial virus-host cell interaction by mono- and diamidines. Antimicrob. Agents Chemother. 19:649-656.
10. Fayer, R., C. Speer, and J. Dubey. 1997. General biology of Cryptosporidium, p. 1-41. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Boca Raton, Fla.
11. Fayer, R., and W. Ellis. 1993. Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice. J. Parasitol. 79:553-558.
12. Fayer, R., and W. Ellis. 1993. Paromomycin is effective as prophylaxis for cryptosporidiosis in dairy calves. J. Parasitol. 78:771-774.
13. Healey, M., C. Yang, S. Rasmussen, M. Jackson, and C. Du. 1995. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum. J. Parasitol. 81:114-116.
14. Hildebrandt, E., D. Boykin, A. Kumar, R. Tidwell, and C. Dykstra. 1998. Identification and characterization of an endo/exonuclease in P. carinii that is inhibited by dicationic diarylfurans with efficacy against P. carinii. J. Eukaryot. Microbiol. 45:112-121.
15. Jones, S., J. Hall, M. Allen, S. Morrison, K. Ohemeng, V. Reddy, J. Geratz, and R. Tidwell. 1990. Novel pentamidine analogs in the treatment of experimental Pneumocytis carinii pneumonia. Antimicrob. Agents Chemother. 34:1026-1030.
16. Lindsay, D., B. Blagburn, and S. Upton. Animal models of Cryptosporidium gastrointestinal infection. In O. Zak and M. Sande (ed.), Handbook of animal models of infection, in press. Academic Press, New York, N.Y.
17. Marshall, R., and T. Flannigan. 1992. Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line. J. Infect. Dis. 165:772-774.
18. Murphy, J., and J. Friedmann. 1985. Pre-clinical toxicology of nitazoxanide - a new antiparasitic compound. J. Appl. Toxicol. 5:49-52.
19. O'Donoghue, P. J. 1995. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol. 25:139-195.
20. Patrick, D., D. Boykin, W. Wilson, B. Bender, J. Hall, C. Dykstra, K. Ohemeng, and R. Tidwell. 1997. Anti-Pneumocystis carinii pneumonia activity of dicationic carbazoles. Eur. J. Med. Chem. 32:781-793.
21. Rose, J., J. Lisle, and M. Lechevallier. 1997. Waterborne cryptosporidiosis: incidence, outbreaks, and treatment strategies, p. 93-109. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Boca Raton, Fla.
22. Tanious, F., D. Ding, D. Patrick, R. Tidwell, and W. Wilson. 1997. A new type of DNA minor-groove complex: carbazole dication-DNA interactions, activity. Biochemistry 36:15315-15325.
23. Tidwell, R., S. Kilgore, J. Geratz, K. Ohemeng, M. Cory, and J. Hall. 1990. Analogues of 1,5-bis (4-amidophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. J. Med. Chem. 33: 1252-1257.
24. Tidwell, R., S. Jones, J. Geratz, K. Ohemeng, C. Bell, B. Berger, and J. Hall. 1990. Development of pentamidine analogues as new agents for the treatment of Pneumocystis carinii pneumonia. Ann. N. Y. Acad. Sci. 616:421-441.
25. Vonderfect, S., R. Miskuff, S. BiWee, S. Sato, R. Tidwell, J. Geratz, and B. Yolken. 1988. Protease inhibitors suppress the in vitro and in vivo replication of rotavirus. J. Clin. Investig. 82:2011-2016.
26. Wilson, W., L. Ratmeyer, M. Zhao, L. Strekowski, and D. Boykin. 1993. The search for structure-specific nucleic acid-interactive drugs. Effects of compound structure on RNA versus DNA interaction strength. Biochemistry 32:4098-4104.